These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38169430)

  • 1. Polymyxins with Potent Antibacterial Activity against Colistin-Resistant Pathogens: Fine-Tuning Hydrophobicity with Unnatural Amino Acids.
    Jørgensen JS; Mood EH; Knap ASH; Nielsen SE; Nielsen PE; Żabicka D; Matias C; Domraceva I; Björkling F; Franzyk H
    J Med Chem; 2024 Jan; 67(2):1370-1383. PubMed ID: 38169430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 4. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History, Chemistry and Antibacterial Spectrum.
    Velkov T; Thompson PE; Azad MAK; Roberts KD; Bergen PJ
    Adv Exp Med Biol; 2019; 1145():15-36. PubMed ID: 31364069
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Duncan LR; Wang W; Sader HS
    Antimicrob Agents Chemother; 2022 May; 66(5):e0013922. PubMed ID: 35475635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the antimicrobial resistance profiles of WHO critical priority list bacterial strains.
    Havenga B; Ndlovu T; Clements T; Reyneke B; Waso M; Khan W
    BMC Microbiol; 2019 Dec; 19(1):303. PubMed ID: 31870288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli.
    Zhang Y; Zhao C; Wang Q; Wang X; Chen H; Li H; Zhang F; Wang H
    J Antimicrob Chemother; 2020 Sep; 75(9):2609-2615. PubMed ID: 32591806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.
    Roberts KD; Zhu Y; Azad MAK; Han ML; Wang J; Wang L; Yu HH; Horne AS; Pinson JA; Rudd D; Voelcker NH; Patil NA; Zhao J; Jiang X; Lu J; Chen K; Lomovskaya O; Hecker SJ; Thompson PE; Nation RL; Dudley MN; Griffith DC; Velkov T; Li J
    Nat Commun; 2022 Mar; 13(1):1625. PubMed ID: 35338128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of dilipid polymyxins: Investigation on the effect of hydrophobicity through its fatty acyl component.
    Domalaon R; Berry L; Tays Q; Zhanel GG; Schweizer F
    Bioorg Chem; 2018 Oct; 80():639-648. PubMed ID: 30053708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performances of the Rapid Polymyxin
    Lescat M; Poirel L; Jayol A; Nordmann P
    Microb Drug Resist; 2019 May; 25(4):520-523. PubMed ID: 30508392
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to polymyxins in Gram-negative organisms.
    Jeannot K; Bolard A; Plésiat P
    Int J Antimicrob Agents; 2017 May; 49(5):526-535. PubMed ID: 28163137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Mutational Scanning Reveals the Active-Site Sequence Requirements for the Colistin Antibiotic Resistance Enzyme MCR-1.
    Sun Z; Palzkill T
    mBio; 2021 Dec; 12(6):e0277621. PubMed ID: 34781730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkyl deoxyglycoside-polymyxin combinations against critical priority carbapenem-resistant gram-negative bacteria.
    de Matos AM; Calado P; Miranda M; Almeida R; Rauter AP; Oliveira MC; Manageiro V; Caniça M
    Sci Rep; 2024 Jan; 14(1):2219. PubMed ID: 38278870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin Resistance Mechanisms: From Intrinsic Resistance to Mcr Genes.
    Meletis G; Skoura L
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):198-206. PubMed ID: 30474535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
    Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
    Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant Gram-negative infections: what are the treatment options?
    Giamarellou H; Poulakou G
    Drugs; 2009 Oct; 69(14):1879-901. PubMed ID: 19747006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.